Go Pro
→ This AI Stock Reminds One Analyst of Early Nvidia (From Brownstone Research) (Ad)tc pixel
OTCMKTS:SKVI

Skinvisible Q2 2026 Earnings Report

$0.20 +0.00 (+0.55%)
As of 03:58 PM Eastern
ProfileEarnings History

Skinvisible EPS Results

Actual EPS
-$0.05
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Skinvisible Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Skinvisible Announcement Details

Quarter
Q2 2026
Date
8/13/2026
Time
During Market Hours
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Skinvisible Earnings Headlines

SKINVISIBLE INC by Skinvisible, Inc. Insider Trading Activity | OTC:SKVI | Benzinga
May 17, 2026  |  benzinga.comhttps://www.benzinga.com/quote/SKVI/insider-trades
Skinvisible Inc.
May 11, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/SKVI/financials
This AI Stock Reminds One Analyst of Early Nvidia
Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company the same size Nvidia was a decade ago. Brown says this firm's patented technology can produce intelligence up to 1,000 times faster than standard AI, and he expects Elon Musk to fuel demand starting November 11. The technology is protected by 150 patents.tc pixel
September 28 at 1:00 AM  |  Brownstone Research (Ad)
Skinvisible Stock Price History
October 9, 2025  |  investing.comhttps://www.investing.com/equities/skinvisible-inc-historical-data
Ovation Science and Skinvisible Pharmaceuticals Enhance Their Strategic Partnership in the Obesity Market with Innovative Cannabinoid Delivery Technology with New Developments ...
September 19, 2025  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/OVATF/pressreleases/34883721/ovation-science-and-skinvisible-pharmaceuticals-enhance-their-strategic-partnership-in-the-obesity-market-with-innovative-cannabinoid-delivery-technology-with-new-developments-and-patent-protection/
Skinvisible Delays 10-K Filing Due to Compilation Issues
March 31, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/skinvisible-delays-10-k-filing-due-to-compilation-issues?utm_source=marketbeat.com&utm_medium=referral
See More Skinvisible Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Skinvisible? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Skinvisible and other key companies, straight to your email.

About Skinvisible

Skinvisible (OTCMKTS:SKVI), Inc. is a specialty healthcare and personal-care company focused on developing topical products and delivery technologies. Its principal technology, Invisicare, is a polymer-based delivery system designed to help keep active ingredients on the skin and improve the performance and usability of topical formulations.

The company has pursued applications for Invisicare in pharmaceutical, cosmetic, antimicrobial, wound-care and personal-care products. Its activities have included developing products internally and working with commercial partners to formulate, license or distribute topical treatments and skin-care products.

Skinvisible has historically operated from the United States and has been described as a development-stage company. Publicly available information about its current operations, product availability, geographic reach and leadership is limited, so the company’s present business status and management structure cannot be described reliably.

View Skinvisible Profile
Earnings Tools